EP 1427755 A2 20040616 - USE OF PEPTIDES COMPRISING POST-TRANSLATIONAL MODIFICATIONS FOR THE PREPARATION OF AGENTS FOR THE TREATMENT OF AUTOIMMUNE PATHOLOGIES
Title (en)
USE OF PEPTIDES COMPRISING POST-TRANSLATIONAL MODIFICATIONS FOR THE PREPARATION OF AGENTS FOR THE TREATMENT OF AUTOIMMUNE PATHOLOGIES
Title (de)
VERWENDUNG VON PEPTIDEN MIT POSTTRANSLATIONALEN MODIFIKATIONEN ZUR BEREITSTELLUNG VON WIRKSTOFFEN ZUR BEHANDLUNG VON AUTOIMMUNERKRANKUNGEN
Title (fr)
UTILISATION DE PEPTIDES COMPORTANT DES MODIFICATIONS DE TYPE POST-TRADUCTIONNEL POUR LA PRÉPARATION D'AGENTS DESTINÉS AU TRAITEMENT DE PATHOLOGIES AUTO-IMMUNES
Publication
Application
Priority
- FR 0203186 W 20020918
- FR 0112041 A 20010918
Abstract (en)
[origin: FR2829768A1] Use of peptides (I), containing epitopes (E) of mammalian self-proteins (II) that are recognized by antibodies produced by mammals suffering from autoimmune disease, also optionally by T helper cells, for preparing a composition for prevention or treatment of such diseases. At least one amino acid in (E) is post-translationally modified. An Independent claim is also included for peptides (Ia) corresponding to the 131-151 amino acid region of the human or murine U1-70K protein and comprising the sequence Arg-Ile-His-Met-Val-Tyr-Ser-Lys-Arg-Ser-Gly-Lys-Pro-Arg-Gly-Tyr-Ala-Ph e-Ile-Glu-Tyr in which at least one amino acid is phosphorylated or acetylated.
IPC 1-7
IPC 8 full level
A61K 38/00 (2006.01); A61P 1/04 (2006.01); A61P 3/10 (2006.01); A61P 17/02 (2006.01); A61P 19/02 (2006.01); A61P 19/04 (2006.01); A61P 25/00 (2006.01); A61P 31/22 (2006.01); A61P 37/00 (2006.01); A61P 37/02 (2006.01); A61P 37/06 (2006.01); C07K 14/47 (2006.01)
CPC (source: EP US)
A61P 1/04 (2017.12 - EP); A61P 3/10 (2017.12 - EP); A61P 17/02 (2017.12 - EP); A61P 19/02 (2017.12 - EP); A61P 19/04 (2017.12 - EP); A61P 25/00 (2017.12 - EP); A61P 29/00 (2017.12 - EP); A61P 31/22 (2017.12 - EP); A61P 37/00 (2017.12 - EP); A61P 37/02 (2017.12 - EP); A61P 37/06 (2017.12 - EP); C07K 14/47 (2013.01 - EP US); A61K 38/00 (2013.01 - EP US)
Citation (search report)
See references of WO 03025014A2
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SK TR
DOCDB simple family (publication)
FR 2829768 A1 20030321; FR 2829768 B1 20031212; AU 2002362383 B2 20081009; CA 2460704 A1 20030327; EP 1427755 A2 20040616; EP 2338908 A1 20110629; JP 2005510469 A 20050421; JP 4160505 B2 20081001; US 2012149652 A1 20120614; US 2014004136 A1 20140102; US 7872098 B1 20110118; US 8475800 B2 20130702; WO 03025014 A2 20030327; WO 03025014 A3 20040219
DOCDB simple family (application)
FR 0112041 A 20010918; AU 2002362383 A 20020918; CA 2460704 A 20020918; EP 02798771 A 20020918; EP 10183969 A 20020918; FR 0203186 W 20020918; JP 2003528859 A 20020918; US 201313914997 A 20130611; US 48996702 A 20020918; US 91323210 A 20101027